Skip to main content

BlackRock, Inc.

For the period ended Jun 30, 2025. Filed Aug 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 6, 2025

BLK$1,222.15+0.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unregistered Sales of Equity Securities and Use of Proceeds

During the three months ended June 30, 2025, the Company made the following purchases of its common stock, which is registered pursuant to Section 12(b) of the Exchange Act.

Total Number of SharesPurchased(1)AveragePrice Paidper ShareTotal Numberof SharesPurchased as Part of PubliclyAnnounced Plans or ProgramsMaximumNumber of Shares that May Yet BePurchased Under the Plans orPrograms(1)
April 1, 2025 April 30, 2025153,826$897.00143,8863,302,159
May 1, 2025 through May 31, 2025239,438$957.75234,7253,067,434
June 1, 2025 through June 30, 202527,914$977.3121,9593,045,475
Total421,178$936.86400,570

(1)

Consists of purchases made by the Company primarily to satisfy income tax withholding obligations of employees and members of the Company’s Board of Directors related to the vesting of certain restricted stock unit awards and purchases made by the Company as part of the share repurchase program that the Company announced in July 2010, which initially authorized the repurchase of 5.1 million shares with no stated expiration. In January 2023, the Company announced that the Board of Directors authorized the repurchase of an additional seven million shares under the Company’s existing share repurchase program, for a total of up to approximately 7.9 million shares of BlackRock common stock.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.